Stylianos Serghiou

Dr. Stylianos Serghiou

Prolaio, Inc, Scottsdale, Arizona, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2021 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
ASAdam Sadilek
Adam Sadilek
LLLuyang Liu
Luyang Liu
DNDung Nguyen
Dung Nguyen
MKMethun Kamruzzaman
Methun Kamruzzaman
SSStylianos Serghiou
Stylianos Serghiou
JHJohn Hernandez
John Hernandez
Privacy protection is paramount in conducting health research. However, studies often rely on data stored in a centralized repository, where analysis is done with full access to the sensitive underlying content. Recent advances in federated learning enable building complex machine-learned models that are trained in a distributed fashion. These techniques facilitate the calculation of research study endpoints such that private data never leaves a given device or healthcare system. We show—on a diverse set of single and multi-site health studies—that federated models can achieve similar accuracy, precision, and generalizability, and lead to the same interpretation as standard centralized statistical models while achieving considerably stronger privacy protections and without significantly raising computational costs. This work is the first to apply modern and general federated learning methods that explicitly incorporate differential privacy to clinical and epidemiological research—across a spectrum of units of federation, model architectures, complexity of learning tasks and diseases. As a result, it enables health research participants to remain in control of their data and still contribute to advancing science—aspects that used to be at odds with each other.

1 March 2021 in PLOS Biology
Verified
Journal Article
Open access
PDF file
SSStylianos Serghiou
Stylianos Serghiou
DCDespina G. Contopoulos-Ioannidis
Despina G. Contopoulos-Ioannidis
KBKevin W. Boyack
Kevin W. Boyack
NRNico Riedel
Nico Riedel
JWJoshua D. Wallach
Joshua D. Wallach
JIJohn P. A. Ioannidis
John P. A. Ioannidis
Recent concerns about the reproducibility of science have led to several calls for more open and transparent research practices and for the monitoring of potential improvements over time. However, with tens of thousands of new biomedical articles published per week, manually mapping and monitoring changes in transparency is unrealistic. We present an open-source, automated approach to identify 5 indicators of transparency (data sharing, code sharing, conflicts of interest disclosures, funding disclosures, and protocol registration) and apply it across the entire open access biomedical literature of 2.75 million articles on PubMed Central (PMC). Our results indicate remarkable improvements in some (e.g., conflict of interest [COI] disclosures and funding disclosures), but not other (e.g., protocol registration and code sharing) areas of transparency over time, and map transparency across fields of science, countries, journals, and publishers. This work has enabled the creation of a large, integrated, and openly available database to expedite further efforts to monitor, understand, and promote transparency and reproducibility in science.

28 June 2016 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
SSStylianos Serghiou
Stylianos Serghiou
AKAIKATERINI KYRIAKOPOULOU
AIKATERINI KYRIAKOPOULOU
JIJohn P. A. Ioannidis
John P. A. Ioannidis
Expression of various long noncoding RNAs (lncRNAs) may affect cancer prognosis. Here, we aim to gather and examine all evidence on the potential role of lncRNAs as novel predictors of survival in human cancer. We systematically searched through PubMed, to identify all published studies reporting on the association between any individual lncRNA or group of lncRNAs with prognosis in human cancer (death or other clinical outcomes). Where appropriate, we then performed quantitative synthesis of those results using meta-analytic methods to identify the true effect size of lncRNAs on cancer prognosis. The reliability of those results was then examined using measures of heterogeneity and testing for selective reporting biases. Three hundred ninety-two studies were screened to eventually identify 111 eligible studies on 127 datasets. In total, these represented 16,754 independent participants pertaining to 53 individual and 6 grouped lncRNAs within a total of 19 cancer sites. Overall, 83 % of the studies we identified addressed overall survival and 32 % of the studies addressed recurrence-free survival. For overall survival, 96 % (88/92) of studies identified a statistically significant association of lncRNA expression to prognosis. Meta-analysis of 6 out of 7 lncRNAs for which three or more studies were available, identified statistically significant associations with overall survival. The lncRNA HOTAIR was by far the most broadly studied lncRNA (n = 29; of 111 studies) and featured a summary hazard ratio (HR) of 2.22 (95 % confidence interval (CI), 1.86–2.65) with modest heterogeneity (I2 = 49 %; 95 % CI, 14–79 %). Prominent excess significance was demonstrated across all meta-analyses (p-value = 0.0003), raising the possibility of substantial selective reporting biases. Multiple lncRNAs have been shown to be strongly associated with prognosis in diverse cancers, but substantial bias cannot be excluded in this field and larger studies are needed to understand whether these prognostic information may eventually be useful.

9 March 2020 in Annual Review of Statistics and Its Application
Verified
Journal Article
Open access
THTom E. Hardwicke
Tom E. Hardwicke
SSStylianos Serghiou
Stylianos Serghiou
PJPerrine Janiaud
Perrine Janiaud
VDValentin Danchev
Valentin Danchev
SCSophia Crüwell
Sophia Crüwell
JIJohn P.A. Ioannidis
John P.A. Ioannidis
While some scientists study insects, molecules, brains, or clouds, other scientists study science itself. Meta-research, or research-on-research, is a burgeoning discipline that investigates efficiency, quality, and bias in the scientific ecosystem, topics that have become especially relevant amid widespread concerns about the credibility of the scientific literature. Meta-research may help calibrate the scientific ecosystem toward higher standards by providing empirical evidence that informs the iterative generation and refinement of reform initiatives. We introduce a translational framework that involves ( a) identifying problems, ( b) investigating problems, ( c) developing solutions, and ( d) evaluating solutions. In each of these areas, we review key meta-research endeavors and discuss several examples of prior and ongoing work. The scientific ecosystem is perpetually evolving; the discipline of meta-research presents an opportunity to use empirical evidence to guide its development and maximize its potential.

12 May 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSStylianos Serghiou
Stylianos Serghiou
RMRebecca M. Marton
Rebecca M. Marton
JIJohn P. A. Ioannidis
John P. A. Ioannidis
The number of retracted articles has grown fast. However, the extent to which researchers and the public are made adequately aware of these retractions and how the media and social media respond to them remains unknown. Here, we aimed to evaluate the media and social media attention received by retracted articles and assess also the attention they receive post-retraction versus pre-retraction. We downloaded all records of retracted literature maintained by the Retraction Watch Database and originally published between January 1, 2010 to December 31, 2015. For all 3,008 retracted articles with a separate DOI for the original and its retraction, we downloaded the respective Altmetric Attention Score (AAS) (from Altmetric) and citation count (from Crossref), for the original article and its retraction notice on June 6, 2018. We also compared the AAS of a random sample of 572 retracted full journal articles available on PubMed to that of unretracted full articles matched from the same issue and journal. 1,687 (56.1%) of retracted research articles received some amount of Altmetric attention, and 165 (5.5%) were even considered popular (AAS>20). 31 (1.0%) of 2,953 with a record on Crossref received >100 citations by June 6, 2018. Popular articles received substantially more attention than their retraction, even after adjusting for attention received post-retraction (Median difference, 29; 95% CI, 17–61). Unreliable results were the most frequent reason for retraction of popular articles (32; 19%), while fake peer review was the most common reason (421; 15%) for the retraction of other articles. In comparison to matched articles, retracted articles tended to receive more Altmetric attention (23/31 matched groups; P-value, 0.01), even after adjusting for attention received post-retraction. Our findings reveal that retracted articles may receive high attention from media and social media and that for popular articles, pre-retraction attention far outweighs post-retraction attention.

1 March 2016 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
SSStylianos Serghiou
Stylianos Serghiou
CPChirag J. Patel
Chirag J. Patel
YTYan Yu Tan
Yan Yu Tan
PKPeter Koay
Peter Koay
JIJohn P.A. Ioannidis
John P.A. Ioannidis